Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Adipose Tissue Derived Mesenchymal Stromal/Stem Cells by Cell2Cure for Diabetic Foot Ulcers: Likelihood of Approval
Adipose Tissue Derived Mesenchymal Stromal/Stem Cells is under clinical development by Cell2Cure and currently in Phase II for Diabetic Foot...
Data Insights
Adipose Tissue Derived Mesenchymal Stromal/Stem Cells by Cell2Cure for Xerostomia: Likelihood of Approval
Adipose Tissue Derived Mesenchymal Stromal/Stem Cells is under clinical development by Cell2Cure and currently in Phase II for Xerostomia. According...